Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2025

Genmab — Februar 2025

Planlagt Fastgjort Låst Flyttet Genmab
699 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #120

    Pfizer forventer fase III data i år på Inclacumab i Sickle Cell Disease

    1 Reply Last reply
    0
    • W Offline
      W Offline
      w
      wrote on sidst redigeret af
      #121

      Nordea og JP påstår igen og igen at jj manglende kommentering af hex er et udtryk for ingen interesse giver ingen mening for mig. Det modsatte havde jo været direkte tåbeligt inden en evt. reforhandsling

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #122

        De prædiker vel blot det der er størst sandsynlighed for. Så er chancen for ikke at tabe ansigt størst.

        1 Reply Last reply
        0
        • W Offline
          W Offline
          w
          wrote on sidst redigeret af
          #123

          Hvorfor overhovedet gi begrundelsen “manglende interesse”.

          1 Reply Last reply
          0
          • R Offline
            R Offline
            Raun
            wrote on sidst redigeret af
            #124

            Der kan kun være en forklaring på den slags gentagelser... - De er blandt de såkaldte spekulanter.... Lur mig de kommer til at tjene kassen.... Ellers synes jeg da bare de skulle have shortet den hver gang de er kommet med disse udmeldinger.... Nåh nej, det virker jo ikke til at skurkene vil tjene penge...

            1 Reply Last reply
            0
            • royalR Offline
              royalR Offline
              royal
              wrote on sidst redigeret af
              #125

              For filan. Der er vel ikke nogen der forventer løbende kommentering indenfor de 60 dage?

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #126

                Godmorgen 🙂

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Stroka
                  wrote on sidst redigeret af
                  #127

                  God morgen 🙂

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    KWC
                    wrote on sidst redigeret af
                    #128

                    RAUN 22.39 Short eller ej ... 🙂

                    1 Reply Last reply
                    0
                    • K Offline
                      K Offline
                      KWC
                      wrote on sidst redigeret af
                      #129

                      Så havde Novod go grund til skepsis gennem tiden.. Det er da tydeligt nu.. Vi er i et sort hul,
                      hvor ingen vil kaste penge ind i..

                      1 Reply Last reply
                      0
                      • K Offline
                        K Offline
                        KWC
                        wrote on sidst redigeret af
                        #130

                        Som Novod sagde...Døde penge.. Men ikke sjovt at se på ... 🙂

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          LP90
                          wrote on sidst redigeret af
                          #131

                          Godmorgen 🙂

                          1 Reply Last reply
                          0
                          • bongobobB Offline
                            bongobobB Offline
                            bongobob
                            wrote on sidst redigeret af
                            #132

                            Not so fun fact: Der er udstedt 20mill aktier siden 2012 og det stopper ikke. Buyback sletter ikke aktier. https://www.macrotrends.net/stocks/charts/GNMSF/genmab/shares-outstanding

                            1 Reply Last reply
                            0
                            • bongobobB Offline
                              bongobobB Offline
                              bongobob
                              wrote on sidst redigeret af
                              #133

                              Genmab bliver ikke en X10 herfra, der er for mange med ved bordet

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Sukkeralf
                                wrote on sidst redigeret af
                                #134

                                Link Preview Image
                                Novo Nordisk A/S: Once-weekly Mim8 is well-tolerated and efficacious in children living with haemophilia A with and without inhibitors

                                Phase 3 FRONTIER3 interim analysis data presented at EAHAD 2025 showed that 74.3% of children on once-weekly Mim8 prophylaxis experienced zero treated bleeds Bagsværd, Denmark, 7 February 2025 – Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed once-weekly prophylaxis treatment (regular treatment to prevent prolonged and spontaneous bleeding) with investig

                                favicon

                                Yahoo Finance (finance.yahoo.com)

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #135

                                  i didn't realise they were this far in children already. Let's hope Novo can speed up the regulatory submission a bit. "At week 26, 98% of caregivers said they preferred Mim8 to prior treatment, of which 73% said they ‘very strongly’ preferred Mim8 to prior treatment."

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #136

                                    Novo Nordisk adds pediatric data to bulging bag of evidence on near-approval hemophilia A prospect https://www.fiercebiotech.com/biotech/novo-adds-pediatric-data-bulging-bag-evidence-near-approval-hemophilia-prospect

                                    1 Reply Last reply
                                    0
                                    • A Offline
                                      A Offline
                                      Aaanditsgone
                                      wrote on sidst redigeret af
                                      #137

                                      "the prior treatment" being Hemlibra, or..?

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #138

                                        whatever they were on before starting this trial; it is not further specified in this data; but as Hemlibra is such a dominant player in this market, i would think your guess would be correct for most patients

                                        1 Reply Last reply
                                        0
                                        • A Offline
                                          A Offline
                                          Aaanditsgone
                                          wrote on sidst redigeret af
                                          #139

                                          Time for an upward adjustment of Mim8 peak sales estimates, perhaps?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper